| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | Injection |
|
Still deciding? Get samples of US$ 10/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
INDICATIONS
This product improves various symptoms induced by the sequelae of cerebral infarction, cerebral hemorrhage and cerebral arteriosclerosis.
Adverse reaction
1. Allergy: sometimes rash, occasional hives, itching and other allergic symptoms may appear, if this symptom occurs, the drug should be discontinued.
2. Mental nervous system: sometimes headache, heavy head, vertigo, occasional drowsiness, numbness of the lateral limbs.
3. Digestive tract: sometimes nausea, vomiting, also occasionally loss of appetite, abdominal pain, diarrhea and other symptoms.
4. Circulatory organs: Sometimes symptoms such as flushing and dizziness may appear, and occasionally symptoms such as hypotension and tachycardia may be seen.
5. Blood: Sometimes there may be a decrease in white blood cells.
6. Liver: Sometimes there may be elevated transaminases, occasionally elevated alkaline phosphatase, jaundice, etc.
7. Kidney: Occasionally, elevated blood urea nitrogen may be seen.
Contraindication
1. Not recommended for those who are allergic to this product.
2. Contraindicated if intracranial hemorrhage has not been completely hemostatic.
3. Contraindicated in severe ischemic heart disease and severe cardiac arrhythmias.
| Support OEM/ODM |
Yes |
| Standard Available |
CP,BP |
| Documents |
GMP,COPP,FSC,CTD |
){kind=link}